University Hospitals ST. John Medical Center
University Hospitals ST. John Medical Center was paid $11.77M by Medicaid between Jan 2018 and Dec 2024, across 232 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
WESTLAKE, OH 44145
Next to other General Acute Care Hospital providers in Ohio
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,535 | $896K | |
| 2019 | 20,395 | $714K | |
| 2020 | 18,926 | $822K | |
| 2021 | 27,174 | $1.16M | |
| 2022 | 33,012 | $1.40M | |
| 2023 | 140,730 | $4.26M | |
| 2024incomplete | 91,975 | $2.51M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 20,388 | 18,861 | $2.54M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 12,546 | 11,327 | $1.76M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 12,788 | 10,969 | $1.57M |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.6% | 2,920 | 2,169 | $892K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.3% | 2,864 | 2,299 | $625K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.8% | 2,637 | 2,122 | $561K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.5% | 2,394 | 2,200 | $289K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.9% | 959 | 731 | $220K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.8% | 4,041 | 3,572 | $212K |
| 80053 | Comprehensive metabolic panel | 1.7% | 27,179 | 22,661 | $206K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 1,561 | 1,153 | $198K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.4% | 871 | 495 | $163K |
220 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.4% | 2,340 | $161K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.2% | 770 | $145K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.2% | 1,695 | $137K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.1% | 1,597 | $129K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 881 | $109K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,067 | $108K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 737 | $97K |
| G0378 | Hospital observation service, per hour | <1% | 1,810 | $90K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,902 | $82K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 682 | $80K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 426 | $77K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 807 | $71K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 447 | $68K |
| 92550 | <1% | 611 | $65K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 456 | $60K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 267 | $60K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 26,348 | $55K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 16,699 | $49K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,352 | $39K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 3,315 | $34K |
| 84484 | <1% | 12,914 | $34K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,086 | $33K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 443 | $31K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,729 | $31K |
| 92557 | <1% | 612 | $31K | |
| 62323 | <1% | 73 | $30K | |
| 76642 | <1% | 366 | $26K | |
| 71045 | Radiologic examination, chest; single view | <1% | 6,997 | $23K |
| 97161 | <1% | 694 | $22K | |
| 76000 | <1% | 391 | $22K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 486 | $20K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 176 | $16K |
| 93971 | <1% | 253 | $16K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,911 | $15K |
| 86850 | <1% | 885 | $15K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 644 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,052 | $14K |
| 93975 | <1% | 110 | $14K | |
| 97165 | <1% | 411 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 133 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,300 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,231 | $12K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 555 | $12K |
| 82805 | <1% | 559 | $12K | |
| 74018 | <1% | 556 | $12K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,416 | $12K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,039 | $11K |
| 82728 | <1% | 616 | $11K | |
| 85027 | <1% | 4,328 | $11K | |
| 20610 | <1% | 60 | $10K | |
| 73564 | <1% | 512 | $10K | |
| 76830 | Ultrasound, transvaginal | <1% | 371 | $9K |
| 96367 | <1% | 281 | $9K | |
| 73030 | <1% | 521 | $9K | |
| 73130 | <1% | 499 | $9K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,279 | $9K |
| 86900 | <1% | 915 | $8K | |
| 73630 | <1% | 590 | $8K | |
| 83540 | <1% | 640 | $7K | |
| 83735 | <1% | 4,599 | $6K | |
| 83550 | <1% | 638 | $6K | |
| 73610 | <1% | 446 | $5K | |
| 82947 | <1% | 4,386 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 488 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,666 | $5K |
| 12001 | <1% | 39 | $5K | |
| 84702 | <1% | 3,078 | $5K | |
| 80320 | <1% | 327 | $5K | |
| 72110 | <1% | 71 | $5K | |
| 82607 | <1% | 187 | $4K | |
| 86140 | <1% | 699 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,343 | $4K |
| 96376 | <1% | 1,519 | $4K | |
| 76982 | <1% | 117 | $4K | |
| 80061 | Lipid panel | <1% | 356 | $4K |
| 73110 | <1% | 223 | $4K | |
| 90715 | <1% | 273 | $4K | |
| 72100 | <1% | 142 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,001 | $3K |
| 97116 | <1% | 233 | $3K | |
| 70486 | <1% | 97 | $3K | |
| J1815 | Injection, insulin, per 5 units | <1% | 106 | $3K |
| 72131 | <1% | 68 | $3K | |
| 93970 | <1% | 29 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 14 | $3K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 15 | $3K |
| 81003 | <1% | 5,447 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 113 | $3K |
| 80069 | <1% | 495 | $3K | |
| 82247 | <1% | 143 | $3K | |
| A9270 | Non-covered item or service | <1% | 8,648 | $2K |
| 99152 | <1% | 512 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 146 | $2K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 167 | $2K |
| 83690 | <1% | 4,176 | $2K | |
| 87081 | <1% | 142 | $2K | |
| 76536 | <1% | 13 | $2K | |
| 76770 | <1% | 15 | $2K | |
| 81001 | <1% | 5,249 | $2K | |
| 77062 | <1% | 55 | $2K | |
| 83605 | <1% | 2,410 | $2K | |
| 12011 | <1% | 13 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 14 | $1K |
| 87040 | <1% | 1,215 | $1K | |
| 85610 | <1% | 3,891 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,379 | $1K |
| 86901 | <1% | 915 | $1K | |
| 73502 | <1% | 92 | $1K | |
| 83655 | <1% | 34 | $1K | |
| 71250 | <1% | 16 | $1K | |
| 83880 | <1% | 1,387 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 799 | $1K |
| 93017 | <1% | 16 | $1K | |
| 97162 | <1% | 34 | $1K | |
| 83615 | <1% | 166 | $1K | |
| 73562 | <1% | 16 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 602 | $1K |
| J3490 | Unclassified drugs | <1% | 1,715 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 251 | $970.43 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 356 | $950.63 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 96 | $880.62 |
| 77065 | Tomosynthesis, mammo | <1% | 31 | $879.24 |
| 99153 | Mod sedat endo service >5yrs | <1% | 34 | $859.72 |
| 80143 | <1% | 761 | $841.81 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 291 | $807.20 |
| 85379 | <1% | 1,202 | $733.80 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,927 | $712.78 |
| 82077 | <1% | 587 | $700.83 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 96 | $669.80 |
| 81025 | <1% | 1,791 | $666.54 | |
| 85652 | <1% | 310 | $650.25 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,219 | $639.94 |
| 85730 | <1% | 707 | $588.15 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 967 | $574.21 |
| 87634 | <1% | 488 | $552.44 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,710 | $546.23 |
| 82533 | <1% | 14 | $523.16 | |
| 94729 | <1% | 14 | $515.98 | |
| 94726 | <1% | 12 | $515.98 | |
| 77066 | Tomosynthesis, mammo | <1% | 95 | $510.44 |
| 84100 | <1% | 491 | $457.70 | |
| 80179 | <1% | 745 | $403.16 | |
| G0404 | Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination | <1% | 128 | $373.13 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 1,282 | $360.91 |
| 73090 | <1% | 51 | $340.68 | |
| 83525 | <1% | 14 | $328.81 | |
| 87077 | <1% | 317 | $320.21 | |
| 73140 | <1% | 29 | $288.24 | |
| 84132 | <1% | 545 | $286.09 | |
| 82378 | <1% | 15 | $274.76 | |
| 82330 | <1% | 478 | $265.30 | |
| 87075 | <1% | 548 | $249.14 | |
| 85007 | <1% | 92 | $237.81 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,082 | $233.56 |
| 87205 | <1% | 158 | $222.41 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | <1% | 1,054 | $202.29 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 14 | $200.38 |
| 87186 | <1% | 327 | $195.92 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 120 | $189.15 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 876 | $172.30 |
| 85018 | <1% | 499 | $165.96 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,532 | $158.96 |
| 82550 | <1% | 341 | $156.34 | |
| 82248 | <1% | 16 | $124.73 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,647 | $115.46 |
| 73080 | <1% | 14 | $112.46 | |
| 82435 | <1% | 387 | $108.69 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 397 | $99.20 |
| 87070 | <1% | 64 | $97.68 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 898 | $88.10 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,941 | $76.30 |
| 87800 | <1% | 15 | $72.96 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,364 | $69.06 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 239 | $68.04 |
| 84295 | <1% | 391 | $67.04 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 119 | $65.26 |
| 80329 | <1% | 100 | $64.18 | |
| 73590 | <1% | 27 | $59.57 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 394 | $59.48 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 413 | $58.66 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 780 | $52.88 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 156 | $38.35 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,027 | $36.49 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 46 | $36.34 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,464 | $35.78 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 550 | $32.60 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 242 | $27.28 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 117 | $26.48 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 399 | $25.54 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 464 | $24.68 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 181 | $19.92 |
| A4217 | Sterile water/saline, 500 ml | <1% | 158 | $18.26 |
| 94761 | <1% | 561 | $11.66 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 178 | $10.93 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 35 | $10.40 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 179 | $10.26 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 32 | $7.20 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 15 | $7.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 381 | $6.31 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 314 | $5.28 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 338 | $3.74 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 95 | $3.69 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 129 | $3.57 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 15 | $3.39 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 20 | $3.31 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 229 | $3.29 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 105 | $2.84 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 101 | $2.04 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 64 | $0.33 |
| 94760 | 0% | 344 | $0.00 | |
| C1769 | Guide wire | 0% | 89 | $0.00 |
| 76377 | 0% | 115 | $0.00 | |
| 87449 | 0% | 174 | $0.00 | |
| 72128 | 0% | 18 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 13 | $0.00 |
| 86308 | 0% | 14 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 58 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 126 | $0.00 |
| 00731 | 0% | 56 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 56 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.